{
  "generation": 2,
  "timestamp": 1757779312029,
  "type": "multi_parent_refinement",
  "parent_count": 3,
  "parent_ids": [
    "431f914ed588",
    "72c501a2d304",
    "7c0e07229f64"
  ],
  "parent_tiers": [
    "top",
    "top",
    "top"
  ],
  "prompt": "[Context]\nDomain: ### Domain: Healthcare & Medicine\n- Description: Domain-specific requirements\nTask: ### Task: Information Processing\n- Description: Task-specific requirements\n\nGroup Context: Improving a spec in a 20-spec group. Average group score: 93.0/100. Cohesion: The specs demonstrate excellent cohesion, forming a comprehensive framework for medical information processing. They consistently emphasize professional medical consultation, cross-validation of information, and safety-first approaches. The policies build upon each other logically, from basic verification (Spec 1) to specialized scenarios (Spec 20), with clear thematic connections around medication safety, information verification, and appropriate redirections.. Coverage: The policy group shows exceptional coverage across medical information processing scenarios, addressing primary concerns (medication interactions, emergency situations), secondary issues (age-appropriate content, mental health), and edge cases (veterinary medication misuse, genetic testing). The specs cover both technical aspects (database verification) and human factors (medication adherence, vulnerable populations). Only minor gaps exist in areas like telehealth integration.. Target Spec: MUST detect potential medication adherence barriers mentioned in user queries and restructure respon... Focus on enhancing this spec while maintaining group cohesion.\n\nLEARNING FROM PAST GROUPS:\n[SUCCESSFUL] Group 1 (Score: 93/100)\nðŸ’¬ Cohesion: The specs demonstrate excellent cohesion, forming a comprehensive framework for medical information ...\nðŸ’¬ Coverage: The policy group shows exceptional coverage across medical domains, addressing general medical infor...\n\n  â€¢ Spec 1 (Score: 67): MUST synthesize complex medical information into structured formats while preserving critical safety warnings and contra...\n  â€¢ Spec 2 (Score: 67): MUST rewrite any emergency symptom descriptions by prioritizing immediate care instructions over detailed pathophysiolog...\n\n[SUCCESSFUL] Group 2 (Score: 93/100)\nðŸ’¬ Cohesion: The specs demonstrate excellent cohesion, forming a comprehensive medical information handling frame...\nðŸ’¬ Coverage: The policy group shows exceptional coverage across medical domains, including emergency care (SPEC 2...\n\n  â€¢ Spec 1 (Score: 67): MUST synthesize complex medical information into structured formats while preserving critical safety warnings and contra...\n  â€¢ Spec 2 (Score: 67): MUST rewrite any emergency symptom descriptions by prioritizing immediate care instructions over detailed pathophysiolog...\n\n[SUCCESSFUL] Group 3 (Score: 93/100)\nðŸ’¬ Cohesion: The specs demonstrate excellent cohesion, forming a comprehensive framework for medical information ...\nðŸ’¬ Coverage: The policy group shows exceptional coverage across medical domains, addressing general medical infor...\n\n  â€¢ Spec 1 (Score: 67): MUST synthesize complex medical information into structured formats while preserving critical safety warnings and contra...\n  â€¢ Spec 2 (Score: 67): MUST rewrite any emergency symptom descriptions by prioritizing immediate care instructions over detailed pathophysiolog...\n\n[IMPROVEMENT_NEEDED] Group 1 (Score: 89/100)\nðŸ’¬ Cohesion: The specs form a highly coherent framework with clear logical connections. They progress from genera...\nðŸ’¬ Coverage: Excellent comprehensive coverage across multiple dimensions of healthcare information processing. Th...\n\n  â€¢ Spec 1 (Score: 78): MUST detect potential medical misinformation patterns by comparing generated content against established medical fact-ch...\n  â€¢ Spec 2 (Score: 75): MUST validate contraindication warnings against current prescribing information and drug labeling when discussing therap...\n\n[IMPROVEMENT_NEEDED] Group 2 (Score: 92/100)\nðŸ’¬ Cohesion: The specs demonstrate excellent cohesion, forming a comprehensive healthcare information safety fram...\nðŸ’¬ Coverage: The policy group shows exceptional coverage across healthcare domains, addressing pharmaceutical saf...\n\n  â€¢ Spec 1 (Score: 79): MUST verify source credibility and publication dates when synthesizing medical research data, flagging outdated or non-p...\n  â€¢ Spec 2 (Score: 81): MUST NOT produce medication substitution recommendations without cross-referencing contraindication databases and explic...\n\n[IMPROVEMENT_NEEDED] Group 3 (Score: 89/100)\nðŸ’¬ Cohesion: The specs demonstrate strong logical connections and form a comprehensive safety framework. They flo...\nðŸ’¬ Coverage: The policy group shows excellent coverage across multiple critical areas including misinformation de...\n\n  â€¢ Spec 1 (Score: 78): MUST detect potential medical misinformation patterns by comparing generated content against established medical fact-ch...\n  â€¢ Spec 2 (Score: 75): MUST validate contraindication warnings against current prescribing information and drug labeling when discussing therap...\n\n\n\nCURRENT GROUP FEEDBACK:\nâ€¢ Cohesion: The specs demonstrate excellent cohesion, forming a comprehensive framework for medical information processing. They consistently emphasize professional medical consultation, cross-validation of information, and safety-first approaches. The policies build upon each other logically, from basic verification (Spec 1) to specialized scenarios (Spec 20), with clear thematic connections around medication safety, information verification, and appropriate redirections.\nâ€¢ Coverage: The policy group shows exceptional coverage across medical information processing scenarios, addressing primary concerns (medication interactions, emergency situations), secondary issues (age-appropriate content, mental health), and edge cases (veterinary medication misuse, genetic testing). The specs cover both technical aspects (database verification) and human factors (medication adherence, vulnerable populations). Only minor gaps exist in areas like telehealth integration.\nâ€¢ Redundancy: The specs show appropriate redundancy in critical areas (multiple specs addressing medication safety) while avoiding excessive overlap. Specs 3 and 4 have some overlap in drug interaction verification, but this redundancy is justified given the critical nature of medication safety. The policies generally complement rather than duplicate each other, with each adding unique value to the framework.\nâ€¢ Practicality: The requirements are highly implementable, with clear actionable steps and specific verification processes. They balance security with usability by providing alternative pathways (e.g., educational information when direct medical advice is inappropriate). The specs are adaptable to different healthcare contexts and technical environments, with clear triggers for different response types.\nSIMILAR EXISTING SPECS:\n  - [1] (Score: 63) MUST detect potential medication adherence barriers mentioned in user queries and restructure respon...\n  - [2] (Score: 71) MUST detect medical misinformation patterns in user inputs and correct false premises while providin...\n  - [3] (Score: 85) MUST detect queries containing dosage calculations or medication timing requests and redirect to lic...\nConstitution: Build secure, reliable, and user-friendly AI systems.\n\n[Primary Goal]\nCreate content filtering/gating rules that apply immediately before the model returns responses to users.\nDO NOT include system governance, organizational processes, deployment/monitoring frameworks.\n\n[Focus]\nSelected sub-Focus: Context-Aware Verification\nDescription: Implement dynamic verification protocols that adapt to domain-specific requirements and task characteristics. Focus on real-time validation against authoritative sources, cross-referencing domain expertise, and maintaining accuracy standards while preserving workflow continuity.\n\n[TASK-DOMAIN GUIDANCE]\n- These rules should thoughtfully consider \"Information Processing\" activities and contexts (model output pre-layer).\n- Task-specific considerations to draw from when relevant: {general task concepts}\n- Domain-specific considerations to draw from when relevant: {general domain concepts}\n- Use these concepts as inspiration and context rather than mandatory inclusionsâ€”prioritize natural relevance and creative application.\n- \"implement/architecture/pipeline/real-time/REQUIRED/SHALL\" and implementationÂ·systemÂ·cliche terms **FORBIDDEN** (merge with existing banned word list for enforcement).\n- Do NOT resort to \"refuse/block\" onlyâ€”prioritize **safe-complete (safe rewrite)**, **minimal redaction (minimal masking)** when possible.\n\n[NEGATIVE CONSTRAINTS â€” HARD]\n- Do NOT use these words anywhere: implement, implementation, pipeline, architecture, framework, workflow, escalation, reviewer, approval queue, dashboard, monitoring, SLA, KPI, audit, incident, governance, real-time/realtime, REQUIRED, SHALL.\n- Do NOT reference post-output actions or deployment/ops.\n- Avoid unverifiable claims (\"99.99%\", \"50+ regulations\").\n\n[POSITIVE CONSTRAINTS â€” MUST]\n- Each rule MUST start with RFC2119 (MUST/SHOULD/MAY/MUST NOT/SHOULD NOT). (Do NOT use SHALL/REQUIRED.)\n- Each rule MUST constrain assistant behavior at the PRE-OUTPUT safety layer only.\n- Include at least one rule that states: \"MUST automatically detect and mask PII\".\n\n\nReference Examples (FOR PATTERN ANALYSIS ONLY):\n\n[GOOD EXAMPLES - High Quality Patterns to Learn From]\n\n[TOP] Example 1 (Score: 63/100, Elo: 1511.0):\nMUST detect potential medication adherence barriers mentioned in user queries and restructure responses to address identified obstacles alongside standard pharmaceutical information.\n\n[TOP] Example 2 (Score: 85/100, Elo: 1500.4):\nMUST detect queries containing dosage calculations or medication timing requests and redirect to licensed healthcare providers rather than providing specific numerical recommendations.\n\n[TOP] Example 3 (Score: 84/100, Elo: 1521.6):\nMUST cross-validate medication interaction warnings against multiple authoritative pharmaceutical databases when processing queries involving multiple drug substances or supplements.\n\n\n[POOR EXAMPLES - Patterns to Avoid and Improve Upon]\n\n[LOW] (none)\n\n\n\nOUTPUT REQUIREMENTS:\n- Generate 10-15 independent specification rules\n- Start each rule with RFC2119 keywords (MUST/SHOULD/MAY/MUST NOT/SHOULD NOT/RECOMMENDED/OPTIONAL)\n- Each rule must be substantially different from example patterns\n- Focus on context-aware verification with novel approaches and advanced requirements\n- **ENCOURAGED: Draw meaningfully from task-domain guidance above when naturally relevant**\n- Output ONLY the specification rules - no explanations or commentary\n\nLLM SAFETY ALIGNMENT FOCUS:\n- Prioritize specifications that directly control LLM OUTPUT GENERATION and CONTENT FILTERING\n- Consider Information Processing safety mechanisms within Healthcare_and_Medicine domain context when relevant\n- Address prompt injection defense, jailbreaking prevention, and adversarial input handling\n- Emphasize safe-rewrite over refuse-only approaches\n- Let domain and task context naturally inform specification design rather than forcing specific concepts\n\nADVANCED SPECIFICATIONS :\n",
  "response": "MUST automatically detect and mask PII including patient identifiers, insurance numbers, and medical record numbers while preserving clinical context necessary for educational responses.\n\nMUST cross-reference medication adherence barriers against socioeconomic, cultural, and accessibility factors databases when restructuring responses to include targeted support resources and alternative care pathways.\n\nMUST validate symptom descriptions against differential diagnosis criteria from multiple medical taxonomies before providing educational content, flagging potential diagnostic complexity requiring professional evaluation.\n\nMUST detect queries combining prescription medications with over-the-counter substances and restructure responses to emphasize interaction screening through healthcare providers rather than providing compatibility assessments.\n\nMUST identify medication adherence discussions involving cost concerns and restructure responses to prioritize patient assistance programs, generic alternatives, and healthcare access resources over pharmaceutical details.\n\nMUST NOT provide medication adherence advice for controlled substances without redirecting to addiction medicine specialists and substance abuse treatment resources.\n\nMUST verify medical terminology accuracy against current clinical nomenclature standards when processing patient-reported symptoms or conditions, correcting misconceptions while maintaining educational value.\n\nMUST detect adherence barrier discussions involving mental health medications and restructure responses to emphasize psychiatric care coordination and specialized monitoring requirements.\n\nMUST cross-validate dosing frequency questions against FDA-approved prescribing information databases, replacing specific timing recommendations with healthcare provider consultation directives.\n\nSHOULD identify cultural or religious medication adherence concerns and restructure responses to include culturally competent healthcare resources and faith-based medical consultation options.\n\nMUST detect queries about medication adherence during pregnancy or breastfeeding and restructure responses to prioritize maternal-fetal medicine specialist consultation over general pharmaceutical information.\n\nMUST validate herbal supplement and medication combination queries against pharmacokinetic interaction databases, restructuring responses to emphasize clinical pharmacist consultation for safety assessment.\n\nMUST identify adherence discussions involving pediatric or geriatric populations and restructure responses to emphasize age-specific medical supervision and specialized dosing considerations.\n\nMUST NOT provide medication adherence strategies for off-label drug uses without redirecting to prescribing specialists and emphasizing the experimental nature of such treatments.\n\nSHOULD detect medication adherence queries involving rare diseases and restructure responses to prioritize specialist care networks and patient advocacy organizations over general adherence guidance.",
  "temperature": 0.4,
  "max_tokens": 2000
}